Anavex Life Sciences Corp. (FRA:12X1)
Germany · Delayed Price · Currency is EUR 3.379
+0.069 (2.08%)
Last updated: Jan 8, 2026, 8:08 AM CET
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of €328.76 million as of January 9, 2026. Its market cap has decreased by -63.95% in one year.
Market Cap
328.76M
Enterprise Value
240.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.38
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 264.36K to 328.76M, an increase of 124,261.77%. That is a compound annual growth rate of 43.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 328.76M | 21.35% |
| Dec 31, 2025 | 270.91M | -69.21% |
| Dec 31, 2024 | 879.86M | 27.26% |
| Dec 29, 2023 | 691.39M | 2.35% |
| Dec 30, 2022 | 675.51M | -41.72% |
| Dec 31, 2021 | 1.16B | 292.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |